Beleave Inc.

December 30, 2015 18:48 ET

Beleave Announces Listing on the Canadian Securities Exchange

TORONTO, ONTARIO--(Marketwired - Dec. 30, 2015) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA OR THROUGH U.S. NEWSWIRE SERVICES

Beleave Inc. (formerly Stream Ventures Inc.) (the "Corporation" or "Beleave") is pleased to announce that the Canadian Securities Exchange ("CSE") has provided final approval to list the Corporation's common shares for trading. Trading of the Corporation's common shares will commence on December 31st, 2015 under the symbol "BE". Information about Beleave can be found in the Corporation's listing statement dated December 23, 2015, which is located on the Corporation's profile at www.sedar.com and on the CSE website. Alternatively you can visit www.beleave.com for additional information.

About Beleave

Beleave Inc. (formerly Stream Ventures Inc.) is a biotech company committed to becoming a licensed producer under the Marihuana for Medical Purposes Regulations (the "MMPR"). Beleave's wholly-owned subsidiary First Access Medical Inc. ("FAM") has applied for a licence to cultivate and sell medical marihuana pursuant to the MMPR. As of the date hereof, FAM has successfully advanced past the security clearance stage and is currently in the review stage of the licensing process. Beleave's purpose built facility is located near Hamilton, Ontario.

Forward Looking Information

This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Corporation believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Corporation can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the completion of the MMPR licensing process and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Corporation's disclosure documents which can be found under the Corporation's profile on www.sedar.com.

Contact Information